Director dealing: Hikma directors keep buying

US public affairs veteran John Castellani, who was appointed to the board in February, spent around £53,000 buying 2,500 shares at a price of 2,103p apiece.

This follows the £600,000 purchase from chief executive Said Darwazah earlier this month and the recent pledge to renew the 10% buyback authority at the annual shareholder meeting.

On Monday one of the top calls from Citi analysts was a 'buy' recommendation on the drugmaker as revised US generics assumptions drove 8-23% upgrades to its EPS forecasts, which still remain below consensus estimates.

"Management has a strong track record of value creation that we argue can continue post the recent Roxane/Bedford deals," Citi said, the Roxane pipeline seen as potentially driving up to 15% EPS upside on offer.

Top Director Buys

Hikma Pharmaceuticals (HIK)
Director name: J. Castellani,John
Amount purchased: 2,500 @ 2,103.00p
Value: £52,575.00

Blackrock Throgmorton Trust (THRG)
Director name: Matterson,Jean
Amount purchased: 6,500 @ 319.35p
Value: £20,757.75

Next Fifteen Communications (NFC)
Director name: Eyre,Richard
Amount purchased: 7,936 @ 252.00p
Value: £19,998.72

Prophotonix (di) (PPIX)
Director name: Losik,Timothy
Amount purchased: 100,000 @ $0.04
Value: $2,883.92

Zotefoams (ZTF)
Director name: Hurst,Clifford G
Amount purchased: 51 @ 289.50p
Value: £147.64

Zotefoams (ZTF)
Director name: Stirling,David
Amount purchased: 51 @ 289.50p
Value: £147.64

Zotefoams (ZTF)
Director name: McGrath ,Gary
Amount purchased: 51 @ 289.50p
Value: £147.64

Meggitt (MGGT)
Director name: Green,Philip Ernest
Amount purchased: 33 @ 388.00p
Value: £128.04

Drs Data & Research Services (DRS)
Director name: Tebbutt,Arthur M
Amount purchased: 1,263 @ 9.90p
Value: £125.04

Meggitt (MGGT)
Director name: Webb,Doug
Amount purchased: 32 @ 388.00p
Value: £124.16

Meggitt (MGGT)
Director name: Young,Stephen G
Amount purchased: 32 @ 388.00p
Value: £124.16

Top Director Sells